Characterization of Niosomes Prepared With Various Nonionic Surfactants for Paclitaxel Oral Delivery

被引:252
作者
Bayindir, Zerrin Sezgin [1 ]
Yuksel, Nilufer [1 ]
机构
[1] Ankara Univ, Sch Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
paclitaxel; formulation; oral drug delivery; niosomes; surfactants; zeta potential; particle size; encapsulation efficiency; gastrointestinal enzymes; stability; FREE INTRAVENOUS MICROEMULSIONS; IN-VITRO; VESICLES NIOSOMES; NANOPARTICLES; FORMULATION; RELEASE; MICELLES; CARRIERS; DRUG; PHOSPHATIDYLETHANOLAMINE;
D O I
10.1002/jps.21944
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonionic surfactant based vesicles (niosomes) are novel drug delivery systems formed from the self-assembly of nonionic amphiphiles in aqueous media. In the present study niosomal formulations of Paclitaxel (PCT), an antineoplastic agent, were prepared using different surfactants (Tween 20, 60, Span 20, 40, 60, Brij 76, 78, 72) by film hydration method. PCT was successfully entrapped in all of the formulations with encapsulation efficiencies ranging between 12.1 +/- 1.36% and 96.6 +/- 0.482%. Z-average sizes of the niosomes were between 229.3 and 588.2 nm. Depending on the addition of the negatively charged dicetyl phosphate to the formulations negative zeta potential values were obtained. High surface charges showed that niosomes can be suspended in water well and this is beneficial for their storage and administration. PCT released from niosomes by a diffusion controlled mechanism. The slow release observed from these formulations might be beneficial for reducing the toxic side effects of PCT. The niosome preparation method was found to be repeatable in terms of size distribution, zeta potential and % drug loading values. The efficiency of niosomes to protect PCT against gastrointestinal enzymes (trypsin, chymotrypsin, and pepsin) was also evaluated for PCT oral delivery. Among all formulations, gastrointestinal stability of PCT was well preserved with Span 40 niosomes. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:2049-2060, 2010
引用
收藏
页码:2049 / 2060
页数:12
相关论文
共 48 条
[1]   Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery [J].
Abdelbary, Ghada ;
El-gendy, Nashwa .
AAPS PHARMSCITECH, 2008, 9 (03) :740-747
[2]  
[Anonymous], INT C HARM TECHN REQ
[3]   Safety and efficacy of amphiphilic β-cyclodextrin nanoparticles for paclitaxel delivery [J].
Bilensoy, Erem ;
Gurkaynak, Oya ;
Dogan, A. Lale ;
Hincal, A. Atilla .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 347 (1-2) :163-170
[4]   Oral particulate delivery: status and future trends [J].
Chen, HM ;
Langer, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :339-350
[5]   Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats [J].
Choi, JS ;
Jo, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 280 (1-2) :221-227
[6]   Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux [J].
Dabholkar, Rupa D. ;
Sawant, Rishikesh M. ;
Mongayt, Dimitriy A. ;
Devarajan, Padma V. ;
Torchilin, Vladimir P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 315 (1-2) :148-157
[7]   Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol [J].
Devaraj, GN ;
Parakh, SR ;
Devraj, R ;
Apte, SS ;
Rao, BR ;
Rambhau, D .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2002, 251 (02) :360-365
[8]   D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(L-lactide) (PLLA) films for localized delivery of paclitaxel [J].
Dong, Yuancai ;
Zhang, Zhiping ;
Feng, Si-Shen .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :166-171
[9]   Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy [J].
Dong, Yuancai ;
Feng, Si-Shen .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 342 (1-2) :208-214
[10]   Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network [J].
Fan, TY ;
Takayama, K ;
Hattori, Y ;
Maitani, Y .
PHARMACEUTICAL RESEARCH, 2004, 21 (09) :1692-1697